Elicio Therapeutics annual gross margin
2020
2021
2022
Elicio Therapeutics Gross Margin Growth & History (ELTX)
Elicio Therapeutics's gross margin was 100.00% for fiscal 2022.
View full Elicio Therapeutics company overviewElicio Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | 100.00% | +1.57 pp |
| 2021 | 2021-12-31 | 98.43% | +615.01 pp |
| 2020 | 2020-12-31 | −516.58% | — |
Elicio Therapeutics quarterly gross margin
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2021 | 2021-12-31 | 98.28% | +63.56 pp |
| Q3 2021 | 2021-09-30 | 100.00% | — |
| Q2 2021 | 2021-06-30 | 100.00% | — |
| Q1 2021 | 2021-03-31 | 100.00% | — |
| Q4 2020 | 2020-12-31 | 34.72% | — |
Elicio Therapeutics gross margin trends
Between the periods ended 2020-12-31 and 2022-12-31, Elicio Therapeutics's gross margin increased from −516.58% to 100.00%, a change of +616.58 percentage points. The latest reported quarter, Q4 2021, shows 98.28%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elicio Therapeutics source filings ↗